I migliori medici di Terapia biologica in Israele — TOP-6 medici

Il Dr. Sarid è specializzato in terapia biologica del cancro presso il Centro Medico Sourasky, con oltre 15 anni di esperienza in oncologia.

• Oncologo senior presso il Centro Medico Sourasky (Ichilov) dal 2009
• Investigatore principale di studi clinici sulle terapie contro il cancro
• Ha pubblicato oltre 30 articoli sul trattamento del cancro
• Membro della Società Europea di Oncologia Medica
• Formazione nel Regno Unito, in Israele e in Georgia

Il Dr. Ari Raphael guida una ricerca genomica rivoluzionaria presso il Sourasky Medical Center, specializzandosi in terapia biologica per le neoplasie toraciche.

• Investigatore principale per studi innovativi di immunoterapia nel cancro ai polmoni
• Leader del progetto dell'Iniziativa Nazionale di Medicina Genomica di Israele
• Membro del consiglio della Società Israeliana di Oncologia Acuta
• Esperto in profilazione genomica completa e biopsie liquide
• Vincitore di numerosi premi per l'eccellenza nell'insegnamento dalla Tel Aviv University

Radiotherapy specialist, Oncologist

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.